Investigative Magnetic Resonance Imaging

Korean Society of Magnetic Resonance in Medicine (대한자기공명의과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Manganese Content on the Magnetic Susceptibility of Ferrous-Manganese Alloys: Correlation between Microstructure on X-Ray Diffraction and Size of the Low-Intensity Area on MRI

  • Youn, Sung Won (Department of Radiology, Catholic University of Daegu, School of Medicine) ;
  • Kim, Moon Jung (Department of Materials Science and Metallurgical Engineering, Kyungpook National University) ;
  • Yi, Seounghoon (Department of Materials Science and Metallurgical Engineering, Kyungpook National University) ;
  • Ahn, Hyun Jin (Department of Pathology, Catholic University of Daegu, School of Medicine) ;
  • Park, Kwan Kyu (Department of Pathology, Catholic University of Daegu, School of Medicine) ;
  • Lee, Jongmin (Department of Radiology, Kyungpook National University, School of Medicine) ;
  • Lee, Young-Cheol (Korea Institute of Industrial Technology Dongnam Technology Application Division)
  • Received : 2015.05.15
  • Accepted : 2015.06.15
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: There is an ongoing search for a stent material that produces a reduced susceptibility artifact. This study evaluated the effect of manganese (Mn) content on the MRI susceptibility artifact of ferrous-manganese (Fe-Mn) alloys, and investigated the correlation between MRI findings and measurements of Fe-Mn microstructure on X-ray diffraction (XRD). Materials and Methods: Fe-Mn binary alloys were prepared with Mn contents varying from 10% to 35% by weight (i.e., 10%, 15%, 20%, 25%, 30%, and 35%; designated as Fe-10Mn, Fe-15Mn, Fe-20Mn, Fe-25Mn, Fe-30Mn, and Fe-35Mn, respectively), and their microstructure was evaluated using XRD. Three-dimensional spoiled gradient echo sequences of cylindrical specimens were obtained in parallel and perpendicular to the static magnetic field (B0). In addition, T1-weighted spin echo, T2-weighted fast spin echo, and $T2^*$weighted gradient echo images were obtained. The size of the low-intensity area on MRI was measured for each of the Fe-Mn binary alloys prepared. Results: Three phases of ${\alpha}^{\prime}$-martensite, ${\gamma}$-austenite, and ${\varepsilon}$-martensite were seen on XRD, and their composition changed from ${\alpha}^{\prime}$-martensite to ${\gamma}$-austenite and/or ${\varepsilon}$-martensite, with increasing Mn content. The Fe-10Mn and Fe-15Mn specimens comprised ${\alpha}^{\prime}$-martensite, the Fe-20Mn and Fe-25Mn specimens comprised ${\gamma}+{\varepsilon}$ phases, and the Fe-30Mn and Fe-35Mn specimens exhibited a single ${\gamma}$ phase. The size of the low-intensity areas of Fe-Mn on MRI decreased relative to its microstructure on XRD with increasing Mn content. Conclusion: Based on these findings, proper conditioning of the Mn content in Fe-Mn alloys will improve its visibility on MR angiography, and a Mn content of more than 25% is recommended to reduce the magnetic susceptibility artifacts on MRI. A reduced artifact of Fe-Mn alloys on MRI is closely related to the paramagnetic constitution of ${\gamma}$-austenite and/or ${\varepsilon}$-martensite.

Keywords

References

  1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-706 https://doi.org/10.1056/NEJM198703193161201
  2. Schomig A, Kastrati A, Mudra H, et al. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-2724 https://doi.org/10.1161/01.CIR.90.6.2716
  3. Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254 https://doi.org/10.1161/01.CIR.94.6.1247
  4. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 2003;89:651-656 https://doi.org/10.1136/heart.89.6.651
  5. Waksman R, Pakala R, Kuchulakanti PK, et al. Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries. Catheter Cardiovasc Interv 2006;68:607-617; discussion 618-619 https://doi.org/10.1002/ccd.20727
  6. Waksman R. Update on bioabsorbable stents: from bench to clinical. J Interv Cardiol 2006;19:414-421 https://doi.org/10.1111/j.1540-8183.2006.00187.x
  7. Erne P, Schier M, Resink TJ. The road to bioabsorbable stents: reaching clinical reality? Cardiovasc Intervent Radiol 2006;29:11-16 https://doi.org/10.1007/s00270-004-0341-9
  8. Peuster M, Wohlsein P, Brugmann M, et al. A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001;86:563-569 https://doi.org/10.1136/heart.86.5.563
  9. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006;27:4955-4962 https://doi.org/10.1016/j.biomaterials.2006.05.029
  10. Hermawan H, Dube D, Mantovani D. Degradable metallic biomaterials: design and development of Fe-Mn alloys for stents. J Biomed Mater Res A 2010;93:1-11
  11. Schinhammer M, Hanzi AC, Loffler JF, Uggowitzer PJ. Design strategy for biodegradable Fe-based alloys for medical applications. Acta Biomater 2010;6:1705-1713 https://doi.org/10.1016/j.actbio.2009.07.039
  12. Liu B, Zheng YF. Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron. Acta Biomater 2011;7:1407-1420 https://doi.org/10.1016/j.actbio.2010.11.001
  13. Buecker A, Spuentrup E, Ruebben A, Gunther RW. Artifactfree in-stent lumen visualization by standard magnetic resonance angiography using a new metallic magnetic resonance imaging stent. Circulation 2002;105:1772-1775 https://doi.org/10.1161/01.CIR.0000015852.60212.DB
  14. Trost DW, Zhang HL, Prince MR, et al. Three-dimensional MR angiography in imaging platinum alloy stents. J Magn Reson Imaging 2004;20:975-980 https://doi.org/10.1002/jmri.20209
  15. O'Brien BJ, Stinson JS, Boismier DA, Carroll WM. Characterization of an NbTaWZr alloy designed for magnetic resonance angiography compatible stents. Biomaterials 2008;29:4540-4545 https://doi.org/10.1016/j.biomaterials.2008.08.013
  16. O'Brien B, Stinson J, Carroll W. Development of a new niobium-based alloy for vascular stent applications. J Mech Behav Biomed Mater 2008;1:303-312 https://doi.org/10.1016/j.jmbbm.2007.11.003
  17. American Society for Testing and Materials (ASTM) standard F2119-07 (2013): Standard test method for evaluation of MR image artifacts from passive implants. http://www.astm.org/Standards/F2119.htm. Accessed June 19, 2015
  18. Port JD, Pomper MG. Quantification and minimization of magnetic susceptibility artifacts on GRE images. J Comput Assist Tomogr 2000;24:958-964 https://doi.org/10.1097/00004728-200011000-00024
  19. Wang Y, Truong TN, Yen C, et al. Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents. Magn Reson Med 2003;49:972-976 https://doi.org/10.1002/mrm.10450
  20. Coecke S, Balls M, Bowe G, et al. Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. Altern Lab Anim 2005;33:261-287 https://doi.org/10.1177/026119290503300313
  21. Gu X, Zheng Y, Cheng Y, Zhong S, Xi T. In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials 2009;30:484-498 https://doi.org/10.1016/j.biomaterials.2008.10.021
  22. Choi JW, Roh HG, Moon WJ, et al. Time-resolved 3D contrast-enhanced MRA on 3.0T: a non-invasive followup technique after stent-assisted coil embolization of the intracranial aneurysm. Korean J Radiol 2011;12:662-670 https://doi.org/10.3348/kjr.2011.12.6.662
  23. Takayama K, Taoka T, Nakagawa H, et al. Usefulness of contrast-enhanced magnetic resonance angiography for follow-up of coil embolization with the enterprise stent for cerebral aneurysms. J Comput Assist Tomogr 2011;35:568-572 https://doi.org/10.1097/RCT.0b013e31822bd498
  24. Seok JH, Choi HS, Jung SL, et al. Artificial luminal narrowing on contrast-enhanced magnetic resonance angiograms on an occasion of stent-assisted coiling of intracranial aneurysm: in vitro comparison using two different stents with variable imaging parameters. Korean J Radiol 2012;13:550-556 https://doi.org/10.3348/kjr.2012.13.5.550
  25. Crossgrove J, Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004;17:544-553 https://doi.org/10.1002/nbm.931
  26. Reaney SH, Bench G, Smith DR. Brain accumulation and toxicity of Mn(II) and Mn(III) exposures. Toxicol Sci 2006;93:114-124 https://doi.org/10.1093/toxsci/kfl028
  27. Chang Y, Jin SU, Kim Y, et al. Decreased brain volumes in manganese-exposed welders. Neurotoxicology 2013;37:182-189 https://doi.org/10.1016/j.neuro.2013.05.003
  28. Chen JY, Tsao GC, Zhao Q, Zheng W. Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol 2001;175:160-168 https://doi.org/10.1006/taap.2001.9245
  29. Hermawan H, Purnama A, Dube D, Couet J, Mantovani D. Fe-Mn alloys for metallic biodegradable stents: degradation and cell viability studies. Acta Biomater 2010;6:1852-1860 https://doi.org/10.1016/j.actbio.2009.11.025

Cited by

  1. Effects of Milling Time and Process Control Agent on the Austenite Stability of Nanocrystalline Fe-10%Mn Alloy Obtained via Spark Plasma Sintering vol.59, pp.7, 2015, https://doi.org/10.2320/matertrans.m2018099
  2. Effect of equal-channel angular pressing on structure and properties of Fe-Mn-С alloys for biomedical applications vol.30, pp.None, 2015, https://doi.org/10.1016/j.mtcomm.2021.103048